National Medical Products Administration (NMPA), China

MPP and the National Medical Products Administration (NMPA), set up directly under the State Council of People’s Republic of China, signed a MoU in October 2018 to improve collaboration and exchange of information for MPP sublicensees based in China. The two parties are especially interested to ensure that MPP’s Chinese sublicensees are able to obtain Certificate of Pharmaceutical Products (COPPs) from NMPA for drugs for which these companies hold voluntary licences.